Mead Johnson Nutrition CO (MJN) : American Century Companies Inc scooped up 732,011 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 5,544,545 shares of Mead Johnson Nutrition CO which is valued at $507,880,322.Mead Johnson Nutrition CO makes up approximately 0.56% of American Century Companies Inc’s portfolio.
Other Hedge Funds, Including , Shell Asset Management Co boosted its stake in MJN in the latest quarter, The investment management firm added 31,234 additional shares and now holds a total of 98,930 shares of Mead Johnson Nutrition CO which is valued at $9,061,988. Mead Johnson Nutrition CO makes up approx 0.21% of Shell Asset Management Co’s portfolio.
Mead Johnson Nutrition CO closed down -0.69 points or -0.77% at $89.2 with 20,67,616 shares getting traded on Friday. Post opening the session at $88.91, the shares hit an intraday low of $88.86 and an intraday high of $90.515 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016. Mead Johnson Nutrition CO was Upgraded by BofA/Merrill to ” Neutral” on Jul 13, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.